Artivion (AORT) Net Equity Issued and Repurchased (2010 - 2026)
Artivion (AORT) posted Net Equity Issued and Repurchased of $1.2 million for Q1 2026, down 63.88% on a QoQ basis from $3.5 million in Q4 2025, and down 70.1% year-over-year from $4.2 million in Q1 2025.
Artivion (AORT) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Artivion's Net Equity Issued and Repurchased history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 70.1% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (up 58.96% YoY) and the FY2025 annual result came in at $13.1 million, up 128.25% from the prior year.
- Net Equity Issued and Repurchased was $1.2 million for Q1 2026 at Artivion, down from $3.5 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $5.2 million in Q3 2025 and bottomed at $24000.0 in Q4 2022.
- A 5-year average of $1.8 million and a median of $1.2 million in 2026 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased sank 89.33% — and 2023, when it surged 1933.33%.
- Artivion's Net Equity Issued and Repurchased stood at $24000.0 in 2022, then jumped by 1933.33% to $488000.0 in 2023, then decreased by 9.22% to $443000.0 in 2024, then soared by 681.26% to $3.5 million in 2025, then slumped by 63.88% to $1.2 million in 2026.
- Business Quant data shows AORT's Net Equity Issued and Repurchased at $1.2 million in Q1 2026, $3.5 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | 1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 278,000.00 |
| Jun 30, 2025 | 278,000.00 |
| Mar 31, 2025 | 4.18 Mn |
| Mar 31, 2025 | 4.18 Mn |
| Dec 31, 2024 | 443,000.00 |
| Dec 31, 2024 | 443,000.00 |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 59,000.00 |
| Mar 31, 2024 | 3.53 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 488,000.00 |
| Dec 31, 2023 | 488,000.00 |